Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s ...

Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response ...